Literature DB >> 16787921

Molecular basis of partial agonism at the neurotransmitter alpha2A-adrenergic receptor and Gi-protein heterotrimer.

Viacheslav O Nikolaev1, Carsten Hoffmann, Moritz Bünemann, Martin J Lohse, Jean-Pierre Vilardaga.   

Abstract

To characterize the mechanism by which heterotrimeric G-proteins interpret the signals coming from various neurotransmitters of diverse efficacies (agonists and partial agonists) acting on alpha(2A)-adrenergic receptors, we used a fluorescent resonance energy transfer-based approach to study the effects of these partial agonists on the activation process of both the alpha(2A)-adrenergic receptor and its cognate G(i)-protein. We show that ligands of different efficacies switch the receptor into distinct conformational states, which in turn set the speed and extent of the G(i)-protein signaling. Thus, in cells the efficacy by which a receptor responds to diverse ligands is caused by the ability of the G-protein to differentiate between distinct receptor conformations. The data provide a new key characteristic underlying the mechanism of partial agonism at G-protein-coupled receptors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16787921     DOI: 10.1074/jbc.M603266200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

Review 1.  Probing heterotrimeric G protein activation: applications to biased ligands.

Authors:  Colette Denis; Aude Saulière; Segolene Galandrin; Jean-Michel Sénard; Céline Galés
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

Review 2.  On the expanding terminology in the GPCR field: the meaning of receptor mosaics and receptor heteromers.

Authors:  Luigi F Agnati; Diego Guidolin; Jean Pierre Vilardaga; Francisco Ciruela; Kjell Fuxe
Journal:  J Recept Signal Transduct Res       Date:  2010-10       Impact factor: 2.092

Review 3.  Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery.

Authors:  Terry Kenakin; Laurence J Miller
Journal:  Pharmacol Rev       Date:  2010-04-14       Impact factor: 25.468

4.  G-protein-coupled receptor heteromer dynamics.

Authors:  Jean-Pierre Vilardaga; Luigi F Agnati; Kjell Fuxe; Francisco Ciruela
Journal:  J Cell Sci       Date:  2010-12-15       Impact factor: 5.285

Review 5.  Ensemble of G protein-coupled receptor active states.

Authors:  P S-H Park
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

Review 6.  Optical probes based on G protein-coupled receptors - added work or added value?

Authors:  A D Stumpf; C Hoffmann
Journal:  Br J Pharmacol       Date:  2015-12-19       Impact factor: 8.739

7.  Pleiotropic beta-agonist-promoted receptor conformations and signals independent of intrinsic activity.

Authors:  Steven M Swift; Mary Rose Schwarb; Kathryn A Mihlbachler; Stephen B Liggett
Journal:  Am J Respir Cell Mol Biol       Date:  2006-09-15       Impact factor: 6.914

Review 8.  Conformational changes in G-protein-coupled receptors-the quest for functionally selective conformations is open.

Authors:  C Hoffmann; A Zürn; M Bünemann; M J Lohse
Journal:  Br J Pharmacol       Date:  2007-12-03       Impact factor: 8.739

Review 9.  Kinetics of G-protein-coupled receptor signals in intact cells.

Authors:  M J Lohse; P Hein; C Hoffmann; V O Nikolaev; J-P Vilardaga; M Bünemann
Journal:  Br J Pharmacol       Date:  2008-01-14       Impact factor: 8.739

Review 10.  GPCR and G proteins: drug efficacy and activation in live cells.

Authors:  Jean-Pierre Vilardaga; Moritz Bünemann; Timothy N Feinstein; Nevin Lambert; Viacheslav O Nikolaev; Stefan Engelhardt; Martin J Lohse; Carsten Hoffmann
Journal:  Mol Endocrinol       Date:  2009-02-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.